Loading the security page…
NYSE American · CLDI
Prices delayed by 15 minutes · 12 November 2026
The series is stated in the current share scale after splits; dividends are not included in the price
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Calidi Biotherapeutics, Inc. (CLDI) is a company in the Health care sector; its shares trade on NYSE American.
The price of Calidi Biotherapeutics, Inc. (CLDI) on November 12, 2026 is 0.6512 $, −3.55 % on the day. Market capitalization is 141,182 $, rank 134 among 134 stocks of the same industry with a known capitalization.
Calidi Biotherapeutics, Inc. trades on NYSE American under the ticker CLDI. The company belongs to the Health care sector. The trading history on this page starts on 1 November 2021.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.0, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
CLDI has a return on equity of −557.71%, below the sector median of −40.58%. Return on assets is −242.55%, below the sector median of −30.08%.